Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 1/2 3Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 267Prostatic Neoplasms 144Neoplasms 140Lung Neoplasms 83Colorectal Neoplasms 61Motor Activity 55Uterine Cervical Neoplasms 44Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 35Colonic Neoplasms 35Head and Neck Neoplasms 34Ovarian Neoplasms 33Brain Neoplasms 32Carcinoma, Hepatocellular 27Neoplasm Metastasis 26Rectal Neoplasms 24Stomach Neoplasms 22Hematologic Neoplasms 20Melanoma 19Endometrial Neoplasms 19Liver Neoplasms 18Anxiety Disorders 18Papillomavirus Infections 16Kidney Neoplasms 16Glioma 16Squamous Cell Carcinoma of Head and Neck 15Fatigue 15Esophageal Neoplasms 15Obesity 14Multiple Myeloma 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Diffuse Intrinsic Pontine Glioma × Clear all
NCT03033992 2026-06-02

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

Children's Oncology Group

Phase NA Active not recruiting
80 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡